Abstract
Background
Retroperitoneal paragangliomas (PGs) are a rare subgroup of neuroendocrine tumors that are commonly located alongside the abdominal aorta. Complete tumor resection is thought to be restricted in patients with major blood vessel involvement. However, no study has specifically focused on aggressive surgical treatment in such patients. We evaluated the value of en bloc resection with major blood vessel reconstruction for locally invasive retroperitoneal PGs.
Methods
Twenty-nine patients with retroperitoneal PGs with major blood vessel involvement were included in this retrospective study. Survival was compared between patients who underwent en bloc resection with major blood vessel reconstruction and those who underwent medical treatment. Prognostic predictors were analyzed in patients who underwent en bloc resection with major blood vessel reconstruction.
Results
All 11 patients who underwent medical treatment obtained a pathological diagnosis by computed tomography-guided percutaneous needle biopsy. All 18 patients who underwent en bloc resection with major blood vessel reconstruction achieved complete tumor resection. Overall survival was higher in patients who underwent complete tumor resection than in those who underwent medical treatment (p < 0.05). No perioperative mortality occurred in patients who underwent complete tumor resection. Patients with no metastasis, no organ invasion, R0 resection, a Ki-67 index of ≤3%, and a tumor diameter of ≤11.7 cm showed better tumor-free survival (p < 0.05).
Conclusions
En bloc resection with major blood vessel reconstruction can be successfully performed and provide satisfactory outcomes for patients with locally invasive retroperitoneal PGs. This technique may become a standard surgical strategy for properly selected patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chen H, Sippel RS, O’Dorisio MS et al (2010) The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 39:775–783
Wen J, Li HZ, Ji ZG et al (2010) A decade of clinical experience with extra-adrenal paragangliomas of retroperitoneum: report of 67 cases and a literature review. Urol Ann 2:12–16
Victoria LM, Karel P (2014) Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Curr Probl Cancer 38:7–41
Timmers HJLM, Pacak K, Huynh TT et al (2008) Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene. J Clin Endocrinol Metab 93:4826–4832
Hemalatha AL, Avadhani GK, Anoosha K et al (2014) Extra-adrenal silent retroperitoneal paraganglioma: report of a rare case. J Clin Diag Res 8:6–7
Sclafani LM, Woodruff JM, Brennan MF et al (1990) Extraadrenal retroperitoneal paragangliomas: natural history and response to treatment. Surgery 108:1124–1130
Ayala-Ramirez M, Feng L, Johnson MM et al (2011) Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab 96:717–725
Martucci VL, Pacak K (2014) Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Curr Probl Cancer 38(1):7–41
Pamela LK, Diane RL, Lowell BA et al (2013) Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas 42:557–577
Baez JC, Jagannathan JP, Krajewski K et al (2012) Pheochromocytoma and paraganglioma: imaging characteristics. Cancer Imaging 12:153–162
Joshua BB, Chandru PS (2007) Laparoscopic resection of an interaortocaval paraganglioma: diagnosis following a needle biopsy. JSLS 11:502–505
Conzo G, Musella M, Corcione F et al (2013) Laparoscopic adrenalectomy, a safe procedure for pheochromocytoma. A retrospective review of clinical series. Int J Surg 11:152–156
Goers TA, Abdo M, Moley JF et al (2013) Outcomes of resection of extra-adrenal pheochromocytomas/paragangliomas in the laparoscopic era: a comparison with adrenal pheochromocytoma. Surg Endosc 27:428–433
Xu WF, Li HZ, Ji ZG et al (2015) Comparison of retroperitoneoscopic versus transperitoneoscopic resection of retroperitoneal paraganglioma: a control study of 74 cases at a single institution. Medicine 94:1–5
Jimenez C, Rohren E, Habra MA et al (2013) Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma. Curr Oncol Rep 15:356–371
Walz MK, Peitgen K, Neumann HPH et al (2002) Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas. World J Surg 26:1005–1012. doi:10.1007/s00268-002-6632-x
Richard EG, James AO, George WH et al (1999) Clinical experience over 48 years with pheochromocytoma. Ann Surg 229:755–766
Park J, Song C, Park M et al (2011) Predictive characteristics of malignant pheochromocytoma. Korean J Urol 52:241–246
Amar L, Baudin E, Burnichon N et al (2007) Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab 92:3822–3828
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare.
Additional information
Hankui Hu and Bin Huang have contributed equally and share the first authorship.
Rights and permissions
About this article
Cite this article
Hu, H., Huang, B., Zhao, J. et al. En Bloc Resection with Major Blood Vessel Reconstruction for Locally Invasive Retroperitoneal Paragangliomas: A 15-Year Experience with Literature Review. World J Surg 41, 997–1004 (2017). https://doi.org/10.1007/s00268-016-3846-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-016-3846-x